Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model

Autor: Daftarian, Narsis, Baigy, Omolbanin, Suri, Fatemeh, Kanavi, Mozhgan Rezaei, Balagholi, Sahar, Afsar Aski, Sasha, Moghaddasi, Afrooz, Nourinia, Ramin, Abtahi, Seyed-Hossein, Ahmadieh, Hamid
Zdroj: In Experimental Eye Research July 2021 208
Databáze: ScienceDirect